Why I Won’t Stop Buying Planet Labs and The only Thing That Will Stop Me
Planet Labs (PL) shares fell 30.17% YTD despite strong Q2 2027 results, with revenue up 58.1% YoY to $116.05M. The company generates positive free cash flow and has a strong recurring revenue model. Management highlights growth opportunities and market share potential, while acknowledging risks like dilution and government contract dependence.
How this was made

The 30-second read
Why it matters
The earnings beat and guidance provide a fresh catalyst that could attract new buying interest, but dilution and government concentration remain risks.
Market read
First‑report earnings with material beat and guidance; relevant for traders tracking space‑tech equities.
What to watch
Potential slowdown in defense spending or loss of a major agency contract would hurt growth.
Background
The author, a retail investor, outlines why they continue buying Planet Labs after a 30% YTD drop despite strong quarterly results.
Ticker impact
Q2 2027 earnings released with revenue $116.05M (+58.1% YoY) and EPS beat, plus full-year guidance $430M‑$441M.
likely upward pressure as investors price in growth and cash generation
Revenue beat, positive free cash flow, and guidance above consensus suggest improved fundamentals.
Market effects
Positive for the Earth‑observation satellite sector, may lift peers.
U.S. investors may increase exposure to space‑tech stocks.
Limited to satellite‑imaging niche but supports broader tech growth narrative.
Counterpoint
High dilution risk from ATM sales and reliance on government contracts could cap upside.
Key entities
- companyPlanet Labs
Satellite imaging firm reporting Q2 2027 results.



